Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin for prevention of hepatorenal syndrome and death in cirrhosis with non-SBP infections
2013-002416-27Phase 4Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Sep 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of albumin (human) in Cirrhosis, hepatorenal syndrome (HRS) and bacterial disease, sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoints: Hospital survival and 28-day survival. Started Sep 2013; status: completed.
02
Drugs
albumin (human)
03
Conditions
Cirrhosishepatorenal syndrome (HRS)bacterial disease
Beyond the preview
Go deeper on 2013-002416-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002416-27.